Healthcare utilization and costs in children with stable and uncontrolled epilepsy

Joyce A Cramer1, Zhixiao J Wang2, Eunice Chang3

  • 1Yale University School of Medicine, New Haven, CT, USA; Consultant, Houston, TX, USA.

Epilepsy & Behavior : E&B
|February 25, 2014
PubMed

Insights

Children with uncontrolled epilepsy incur higher healthcare costs and utilization than those with stable epilepsy. Uncontrolled epilepsy significantly impacts pediatric economic burden and resource use.

Area of Science:

  • Pediatric Healthcare Economics
  • Neurology
  • Public Health

Background:

  • Epilepsy significantly impacts childhood development and can lead to substantial economic burdens in pediatric populations.
  • Understanding healthcare utilization and associated costs is crucial for managing pediatric epilepsy effectively.

Purpose of the Study:

  • To compare annual healthcare utilization and costs between children under 12 with stable versus uncontrolled epilepsy.
  • To assess the economic impact of uncontrolled epilepsy in pediatric patients treated with antiepileptic drugs (AEDs).

Main Methods:

  • A retrospective analysis of the MarketScan claims database (2007-2009) identified children (<12 years) with epilepsy.
  • Patients were categorized as having "stable" epilepsy (same AED for ≥12 months) or "uncontrolled" epilepsy (additional AEDs prescribed).
  • Epilepsy-related utilization and costs were analyzed, adjusting for baseline differences using logistic regression and ANCOVA.

Main Results:

  • Children with uncontrolled epilepsy experienced higher hospitalization rates (30.1% vs. 12.0%) and significantly greater overall and epilepsy-related costs.
  • Adjusted analyses showed uncontrolled epilepsy was associated with increased odds of hospitalization (OR: 2.5) and higher epilepsy-related costs ($5744).
  • Despite significant epilepsy-related expenses, comorbid conditions contributed substantially to the overall economic burden.

Conclusions:

  • Uncontrolled epilepsy in children leads to significantly higher healthcare resource utilization and economic burden compared to stable epilepsy.
  • The findings highlight the need for effective management strategies to control epilepsy and mitigate its economic impact on pediatric populations.
  • Comorbidities play a significant role in the overall healthcare costs associated with childhood epilepsy.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
47
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
42
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K